Clara Redondo
Quality Assurance Lead
I joined Oxford Cancer Trials as a Trial Administrator in March 2017. Prior to this I was a Postdoctoral Researcher developing inhibitors for specific kinases selected as targets for therapeutic interventions, at the Structural Genomics Consortium in Oxford.
My current role focuses on the set-up, activation and follow-up activities, amendment processing and team communications in a varied portfolio of Oncological and Haematological Trials. I was promoted to take the lead for Quality Assurance in the Unit in 2023.